Drug Profile
Artilide
Alternative Names: U 88943ELatest Information Update: 24 Mar 1997
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Class III antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 24 Mar 1997 No-Development-Reported for Arrhythmias in USA (PO)
- 24 Oct 1994 Phase-I clinical trials for Arrhythmias in USA (PO)